The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Bacteria and Host Interplay in Staphylococcus aureus Septic Arthritis and Sepsis
Abstract
Staphylococcus aureus (S. aureus) infections are a major healthcare challenge and new treatment alternatives are needed. S. aureus septic arthritis, a debilitating joint disease, causes permanent joint dysfunction in almost 50% of the patients. S. aureus bacteremia is associated with higher mortalities than bacteremia caused by most other microbes and can develop to severe sepsis and death. The key to new therapies is understanding the interplay between bacterial virulence factors and host immune response, which decides the disease outcome. S. aureus produces numerous virulence factors that facilitate bacterial dissemination, invasion into joint cavity, and cause septic arthritis. Monocytes, activated by several components of S. aureus such as lipoproteins, are responsible for bone destructions. In S. aureus sepsis, cytokine storm induced by S. aureus components leads to the hyperinflammatory status, DIC, multiple organ failure, and later death. The immune suppressive therapies at the very early time point might be protective. However, the timing of treatment is crucial, as late treatment may aggravate the immune paralysis and lead to uncontrolled infection and death.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some strains produce staphylokinase, an enzyme that degrades antimicrobial peptides, reducing host immune clearance [21,22].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neutrophil recruitment and function in health and inflammation
Kolaczkowska, E., & Kubes, P. (2013) · Nature Reviews Immunology · doi:10.1038/nri3399 · Cited by 5,472
The Human Intestinal Microbiome in Health and Disease
Lynch, S. V., & Pedersen, O. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1600266 · Cited by 3,637 · cited 1×
“Microbiome, a diverse community of microorganisms and the environment that they occupy, has been shown to be associated with human diseases, such as metabolic disorders, respiratory diseases, autoimmune diseases, and psychological disorders [158].”
BackgroundCpG motifs in bacterial DNA trigger direct B-cell activation
Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M. (1995) · Nature · doi:10.1038/374546a0 · Cited by 3,508
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Scheller, J., Chalaris, A., Schmidt-Arras, D., & Rose-John, S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.034 · Cited by 3,212
The role of nasal carriage in Staphylococcus aureus infections
Wertheim, H. F., Melles, D. C., Vos, M. C., van Leeuwen, W., van Belkum, A., Verbrugh, H. A., & Nouwen, J. L. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70295-4 · Cited by 2,685
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
Tracey, K. J., Fong, Y., Hesse, D. G., Manogue, K. R., Lee, A. T., Kuo, G. C., Lowry, S. F., & Cerami, A. (1987) · Nature · doi:10.1038/330662a0 · Cited by 2,448 · cited 1×
“Already in 1987, the TNF inhibitor was shown to prevent septic shock in lethal bacteremia in baboons [176].”
BackgroundInterleukin-1 in the pathogenesis and treatment of inflammatory diseases
Dinarello, C. A. (2011) · Blood · doi:10.1182/blood-2010-07-273417 · Cited by 2,248 · cited 1×
“It plays an important role in pain, inflammation, and cartilage degradation in several inflammatory diseases [131].”
BackgroundMSCRAMM-MEDIATED ADHERENCE OF MICROORGANISMS TO HOST TISSUES
Patti, J. M., Allen, B. L., McGavin, M. J., & Höök, M. (1994) · Annual Review of Microbiology · doi:10.1146/annurev.mi.48.100194.003101 · Cited by 1,191 · cited 4×
“Microbial surface components recognizing adhesive matrix molecules (MSCRAMMs) are S. aureus surface proteins that are anchored on the cell wall PGN.”
BackgroundInfluentialInfection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo
Yipp, B. G., Petri, B., Salina, D., Jenne, C. N., Scott, B. N. V., Zbytnuik, L. D., Pittman, K., Asaduzzaman, M., Wu, K., Meijndert, H. C., et al. (2012) · Nature Medicine · doi:10.1038/nm.2847 · Cited by 1,169
Taur, Y., Xavier, J. B., Lipuma, L., Ubeda, C., Goldberg, J., Gobourne, A., Lee, Y. J., Dubin, K. A., Socci, N. D., Viale, A., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis580 · Cited by 1,020
Research works printed but not linked: 169
- Bien, 2011, Characterization of Virulence Factors of Staphylococcus aureus: Novel Function of Known Virulence Factors That Are Implicated in Activation of Airway Epithelial Proinflammatory Response, J. Pathog., 2011, 601905
- Ali, A. (2016). Biologics in Staphylococcus Aureus Arthritis. [Ph.D. Thesis, University of Gothenburg].
- Nanra, 2013, Capsular polysaccharides are an important immune evasion mechanism for Staphylococcus aureus, Hum. Vaccin. Immunother., 9, 480, 10.4161/hv.23223 · doi:10.4161/hv.23223
- Nilsson, 1997, The role of staphylococcal polysaccharide microcapsule expression in septicemia and septic arthritis, Infect. Immun., 65, 4216, 10.1128/iai.65.10.4216-4221.1997 · DOI
- Watts, 2005, Staphylococcus aureus strains that express serotype 5 or serotype 8 capsular polysaccharides differ in virulence, Infect. Immun., 73, 3502, 10.1128/IAI.73.6.3502-3511.2005 · doi:10.1128/iai.73.6.3502-3511.2005
- Sharif, 2009, Staphylococcus aureus peptidoglycan tertiary structure from carbon-13 spin diffusion, J. Am. Chem. Soc., 131, 7023, 10.1021/ja808971c · DOI
- Vollmer, 2008, Peptidoglycan structure and architecture, FEMS Microbiol. Rev., 32, 149, 10.1111/j.1574-6976.2007.00094.x · DOI · Paper page
- Willey, J.M., Sherwood, L., and Woolverton, C.J. (2014). Prescott’s Microbiology, McGraw-Hill. [9th ed.].
- Grundling, 2006, Cross-linked peptidoglycan mediates lysostaphin binding to the cell wall envelope of Staphylococcus aureus, J. Bacteriol., 188, 2463, 10.1128/JB.188.7.2463-2472.2006 · DOI · Paper page
- Kashyap, 2011, Peptidoglycan recognition proteins kill bacteria by activating protein-sensing two-component systems, Nat. Med., 17, 676, 10.1038/nm.2357 · DOI · Paper page
- Liu, 2001, Staphylococcal peptidoglycans induce arthritis, Arthritis Res. Ther., 3, 375, 10.1186/ar330 · DOI
- Dusad, 2013, Organic dust, lipopolysaccharide, and peptidoglycan inhalant exposures result in bone loss/disease, Am. J. Respir. Cell Mol. Biol., 49, 829, 10.1165/rcmb.2013-0178OC · DOI
- Mohammad, M., Nguyen, M.T., Engdahl, C., Na, M., Jarneborn, A., Hu, Z., Karlsson, A., Pullerits, R., Ali, A., and Gotz, F. (2019). The YIN and YANG of lipoproteins in developing and preventing infectious arthritis by Staphylococcus aureus. PLoS Pathog., 15. · DOI
- Bera, 2005, Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus, Mol. Microbiol., 55, 778, 10.1111/j.1365-2958.2004.04446.x · DOI · Paper page
- Sychantha, D., Jones, C.S., Little, D.J., Moynihan, P.J., Robinson, H., Galley, N.F., Roper, D.I., Dowson, C.G., Howell, P.L., and Clarke, A.J. (2017). In vitro characterization of the antivirulence target of Gram-positive pathogens, peptidoglycan O-acetyltransferase A (OatA). PLoS Pathog., 13. · DOI
- Baranwal, 2017, Impact of cell wall peptidoglycan O-acetylation on the pathogenesis of Staphylococcus aureus in septic arthritis, Int. J. Med. Microbiol., 307, 388, 10.1016/j.ijmm.2017.08.002 · DOI
- Reichmann, 2011, Location, synthesis and function of glycolipids and polyglycerolphosphate lipoteichoic acid in Gram-positive bacteria of the phylum Firmicutes, FEMS Microbiol. Lett., 319, 97, 10.1111/j.1574-6968.2011.02260.x · DOI · Paper page
- Brown, 2013, Wall teichoic acids of gram-positive bacteria, Annu. Rev. Microbiol., 67, 313, 10.1146/annurev-micro-092412-155620 · DOI · Paper page
- Morath, 2001, Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus, J. Exp. Med., 193, 393, 10.1084/jem.193.3.393 · DOI · Paper page
- Morath, 2002, Synthetic lipoteichoic acid from Staphylococcus aureus is a potent stimulus of cytokine release, J. Exp. Med., 195, 1635, 10.1084/jem.20020322 · DOI · Paper page
- Nguyen, 2016, Lipoproteins of Gram-Positive Bacteria: Key Players in the Immune Response and Virulence, Microbiol. Mol. Biol. Rev., 80, 891, 10.1128/MMBR.00028-16 · DOI · Paper page
- Sheldon, 2012, The iron-regulated staphylococcal lipoproteins, Front. Cell. Infect. Microbiol., 2, 41, 10.3389/fcimb.2012.00041 · DOI
- Nguyen, 2017, Lipid moieties on lipoproteins of commensal and non-commensal staphylococci induce differential immune responses, Nat. Commun., 8, 2246, 10.1038/s41467-017-02234-4 · DOI
- Mohammad, 2020, The role of Staphylococcus aureus lipoproteins in hematogenous septic arthritis, Sci. Rep., 10, 7936, 10.1038/s41598-020-64879-4 · DOI
- Schmaler, 2009, Lipoproteins in Staphylococcus aureus mediate inflammation by TLR2 and iron-dependent growth in vivo, J. Immunol., 182, 7110, 10.4049/jimmunol.0804292 · DOI
- Nguyen, M.T., Kraft, B., Yu, W., Demircioglu, D.D., Hertlein, T., Burian, M., Schmaler, M., Boller, K., Bekeredjian-Ding, I., and Ohlsen, K. (2015). The νSaα Specific Lipoprotein Like Cluster (lpl) of S. aureus USA300 Contributes to Immune Stimulation and Invasion in Human Cells. PLoS Pathog., 11. · doi:10.1371/journal.ppat.1005189
- Foster, 2014, Adhesion, invasion and evasion: The many functions of the surface proteins of Staphylococcus aureus, Nat. Rev. Microbiol., 12, 49, 10.1038/nrmicro3161 · DOI · Paper page
- Hair, 2010, Clumping factor A interaction with complement factor I increases C3b cleavage on the bacterial surface of Staphylococcus aureus and decreases complement-mediated phagocytosis, Infect. Immun., 78, 1717, 10.1128/IAI.01065-09 · DOI
- Josefsson, 2001, Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant, J. Infect. Dis., 184, 1572, 10.1086/324430 · DOI · Paper page
- Kobayashi, 2013, Staphylococcus aureus protein A promotes immune suppression, MBio, 4, e00764-13, 10.1128/mBio.00764-13 · DOI
- Palmqvist, 2002, Protein A is a virulence factor in Staphylococcus aureus arthritis and septic death, Microb. Pathog., 33, 239, 10.1006/mpat.2002.0533 · DOI · Paper page
- Palmqvist, 2005, Fibronectin-binding proteins and fibrinogen-binding clumping factors play distinct roles in staphylococcal arthritis and systemic inflammation, J. Infect. Dis., 191, 791, 10.1086/427663 · doi:10.1086/427663
- Switalski, 1993, A collagen receptor on Staphylococcus aureus strains isolated from patients with septic arthritis mediates adhesion to cartilage, Mol. Microbiol., 7, 99, 10.1111/j.1365-2958.1993.tb01101.x · DOI · Paper page
- Patti, 1994, The Staphylococcus aureus collagen adhesin is a virulence determinant in experimental septic arthritis, Infect. Immun., 62, 152, 10.1128/iai.62.1.152-161.1994 · DOI · Paper page
- Vanassche, 2011, Inhibition of staphylothrombin by dabigatran reduces Staphylococcus aureus virulence, J. Thromb. Haemost., 9, 2436, 10.1111/j.1538-7836.2011.04529.x · DOI
- Na, M., Hu, Z., Mohammad, M., Stroparo, M.D.N., Ali, A., Fei, Y., Jarneborn, A., Verhamme, P., Schneewind, O., and Missiakas, D. (2020). The Expression of von Willebrand Factor-Binding Protein Determines Joint-Invading Capacity of Staphylococcus aureus, a Core Mechanism of Septic Arthritis. mBio, 11. · doi:10.1128/mbio.02472-20
- Hammel, 2007, The Staphylococcus aureus extracellular adherence protein (Eap) adopts an elongated but structured conformation in solution, Protein Sci., 16, 2605, 10.1110/ps.073170807 · DOI
- Zecconi, 2013, Staphylococcus aureus virulence factors in evasion from innate immune defenses in human and animal diseases, Immunol. Lett., 150, 12, 10.1016/j.imlet.2013.01.004 · DOI · Paper page
- Kwiecinski, 2013, Staphylokinase Promotes the Establishment of Staphylococcus aureus Skin Infections While Decreasing Disease Severity, J. Infect. Dis., 208, 990, 10.1093/infdis/jit288 · DOI
- Xu, 2012, Staphylococcal superantigens in colonization and disease, Front. Cell. Infect. Microbiol., 2, 52, 10.3389/fcimb.2012.00052 · DOI · Paper page
- McCormick, 2003, Functional analysis of the TCR binding domain of toxic shock syndrome toxin-1 predicts further diversity in MHC class II/superantigen/TCR ternary complexes, J. Immunol., 171, 1385, 10.4049/jimmunol.171.3.1385 · doi:10.4049/jimmunol.171.3.1385
- Abdelnour, 1994, Clonal expansion of T lymphocytes causes arthritis and mortality in mice infected with toxic shock syndrome toxin-1-producing staphylococci, Eur. J. Immunol., 24, 1161, 10.1002/eji.1830240523 · DOI
- Dinges, 2000, Exotoxins of Staphylococcus aureus, Clin. Microbiol. Rev., 13, 16, 10.1128/CMR.13.1.16 · DOI · Paper page
- Omoe, 2013, Emetic potentials of newly identified staphylococcal enterotoxin-like toxins, Infect. Immun., 81, 3627, 10.1128/IAI.00550-13 · doi:10.1128/iai.00550-13
- Nilsson, 1999, Alpha-toxin and gamma-toxin jointly promote Staphylococcus aureus virulence in murine septic arthritis, Infect. Immun., 67, 1045, 10.1128/IAI.67.3.1045-1049.1999 · DOI
- Cheung, 2014, Phenol-soluble modulins--critical determinants of staphylococcal virulence, FEMS Microbiol. Rev., 38, 698, 10.1111/1574-6976.12057 · DOI · Paper page
- Periasamy, 2012, How Staphylococcus aureus biofilms develop their characteristic structure, Proc. Natl. Acad. Sci. USA, 109, 1281, 10.1073/pnas.1115006109 · DOI · Paper page
- Peschel, 2013, Phenol-soluble modulins and staphylococcal infection, Nat. Rev. Microbiol., 11, 667, 10.1038/nrmicro3110 · DOI · Paper page
- Rasigade, J.P., Trouillet-Assant, S., Ferry, T., Diep, B.A., Sapin, A., Lhoste, Y., Ranfaing, J., Badiou, C., Benito, Y., and Bes, M. (2013). PSMs of hypervirulent Staphylococcus aureus act as intracellular toxins that kill infected osteoblasts. PLoS ONE, 8. · DOI
- Fournier, 2005, Recognition of Staphylococcus aureus by the innate immune system, Clin. Microbiol. Rev., 18, 521, 10.1128/CMR.18.3.521-540.2005 · DOI · Paper page
- Deng, 1999, Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis, Nat. Med., 5, 702, 10.1038/9554 · DOI · Paper page
- Sparwasser, 1997, Bacterial DNA causes septic shock, Nature, 386, 336, 10.1038/386336a0 · DOI · Paper page
- Joh, 1999, Role of fibronectin-binding MSCRAMMs in bacterial adherence and entry into mammalian cells, Matrix Biol., 18, 211, 10.1016/S0945-053X(99)00025-6 · DOI · Paper page
- An, Y.H., and Friedman, R.J. (2000). Handbook of Bacterial Adhesion Principles, Methods, and Applications, Humana Press.
- Chavakis, 2005, Staphylococcus aureus interactions with the endothelium: The role of bacterial “secretable expanded repertoire adhesive molecules” (SERAM) in disturbing host defense systems, Thromb. Haemost., 94, 278, 10.1160/TH05-05-0306 · DOI · Paper page
- Claes, 2014, Adhesion of Staphylococcus aureus to the vessel wall under flow is mediated by von Willebrand factor-binding protein, Blood, 124, 1669, 10.1182/blood-2014-02-558890 · doi:10.1182/blood-2014-02-558890
- Claes, 2017, Clumping factor A, von Willebrand factor-binding protein and von Willebrand factor anchor Staphylococcus aureus to the vessel wall, J. Thromb. Haemost., 15, 1009, 10.1111/jth.13653 · DOI
- Bardoel, 2012, Evasion of Toll-like receptor 2 activation by staphylococcal superantigen-like protein 3, J. Mol. Med. (Berl.), 90, 1109, 10.1007/s00109-012-0926-8 · DOI
- Ibberson, 2014, Staphylococcus aureus hyaluronidase is a CodY-regulated virulence factor, Infect. Immun., 82, 4253, 10.1128/IAI.01710-14 · DOI
- Kwiecinski, 2016, Staphylokinase Control of Staphylococcus aureus Biofilm Formation and Detachment Through Host Plasminogen Activation, J. Infect. Dis., 213, 139, 10.1093/infdis/jiv360 · DOI
- Fraser, J.D. (2011). Clarifying the mechanism of superantigen toxicity. PLoS Biol., 9. · DOI
- McCormick, 2001, Toxic shock syndrome and bacterial superantigens: An update, Annu. Rev. Microbiol., 55, 77, 10.1146/annurev.micro.55.1.77 · DOI · Paper page
- Marrack, 1990, The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells, J. Exp. Med., 171, 455, 10.1084/jem.171.2.455 · DOI · Paper page
- Kaempfer, 2013, CD28: Direct and critical receptor for superantigen toxins, Toxins (Basel), 5, 1531, 10.3390/toxins5091531 · DOI
- Gouaux, 1998, alpha-Hemolysin from Staphylococcus aureus: An archetype of beta-barrel, channel-forming toxins, J. Struct. Biol., 121, 110, 10.1006/jsbi.1998.3959 · DOI · Paper page
- Deng, 2001, Intracisternally localized bacterial DNA containing CpG motifs induces meningitis, J. Immunol., 167, 4616, 10.4049/jimmunol.167.8.4616 · DOI
- Ali, 2015, Antibiotic-killed Staphylococcus aureus induces destructive arthritis in mice, Arthritis Rheumatol., 67, 107, 10.1002/art.38902 · DOI
- Verdrengh, 1997, Role of neutrophils in experimental septicemia and septic arthritis induced by Staphylococcus aureus, Infect. Immun., 65, 2517, 10.1128/iai.65.7.2517-2521.1997 · DOI · Paper page
- Verdrengh, 2000, Role of macrophages in Staphylococcus aureus-induced arthritis and sepsis, Arthritis Rheum., 43, 2276, 10.1002/1529-0131(200010)43:10<2276::AID-ANR15>3.0.CO;2-C · doi:10.1002/1529-0131(200010)43:10<2276::aid-anr15>3.0.co;2-c
- Nilsson, 1999, Protective role of NK1.1+ cells in experimental Staphylococcus aureus arthritis, Clin. Exp. Immunol., 117, 63, 10.1046/j.1365-2249.1999.00922.x · DOI
- Krishack, P.A., Louviere, T.J., Decker, T.S., Kuzel, T.G., Greenberg, J.A., Camacho, D.F., Hrusch, C.L., Sperling, A.I., and Verhoef, P.A. (2019). Protection against Staphylococcus aureus bacteremia-induced mortality depends on ILC2s and eosinophils. JCI Insight, 4. · DOI
- Abdelnour, 1994, Role of T lymphocytes in experimental Staphylococcus aureus arthritis, Scand. J. Immunol., 39, 403, 10.1111/j.1365-3083.1994.tb03392.x · doi:10.1111/j.1365-3083.1994.tb03392.x
- Bergmann, B., Fei, Y., Jirholt, P., Hu, Z., Bergquist, M., Ali, A., Lindholm, C., Ekwall, O., Churlaud, G., and Klatzmann, D. (2020). Pre-treatment with IL2 gene therapy alleviates Staphylococcus aureus arthritis in mice. BMC Infect. Dis., 20. · DOI
- Gjertsson, 2000, Are B lymphocytes of importance in severe Staphylococcus aureus infections?, Infect. Immun., 68, 2431, 10.1128/IAI.68.5.2431-2434.2000 · DOI
- Wuescher, 2015, A novel conditional platelet depletion mouse model reveals the importance of platelets in protection against Staphylococcus aureus bacteremia, J. Thromb. Haemost., 13, 303, 10.1111/jth.12795 · DOI
- Piliponsky, 2019, Basophil-derived tumor necrosis factor can enhance survival in a sepsis model in mice, Nat. Immunol., 20, 129, 10.1038/s41590-018-0288-7 · DOI
- Akira, 2006, Pathogen recognition and innate immunity, Cell, 124, 783, 10.1016/j.cell.2006.02.015 · DOI · Paper page
- Abbas, A.K., and Lichtman, A.H. (2009). Basic Immunology: Functions and Disorders of the Immune System, Saunders/Elsevier. [3rd ed.].
- Molne, 2000, Role of neutrophil leukocytes in cutaneous infection caused by Staphylococcus aureus, Infect. Immun., 68, 6162, 10.1128/IAI.68.11.6162-6167.2000 · DOI
- Mills, 2015, Anatomy of a discovery: m1 and m2 macrophages, Front. Immunol., 6, 212, 10.3389/fimmu.2015.00212 · DOI · Paper page
- Rath, 2014, Metabolism via Arginase or Nitric Oxide Synthase: Two Competing Arginine Pathways in Macrophages, Front. Immunol., 5, 532, 10.3389/fimmu.2014.00532 · DOI · Paper page
- Mosser, 2008, Exploring the full spectrum of macrophage activation, Nat. Rev. Immunol., 8, 958, 10.1038/nri2448 · DOI · Paper page
- Makita, 2015, IL-10 enhances the phenotype of M2 macrophages induced by IL-4 and confers the ability to increase eosinophil migration, Int. Immunol., 27, 131, 10.1093/intimm/dxu090 · DOI · Paper page
- Tanaka, 2005, Osteoblasts and osteoclasts in bone remodeling and inflammation, Curr. Drug Targets Inflamm. Allergy, 4, 325, 10.2174/1568010054022015 · DOI · Paper page
- Ogata, 1999, A novel role of IL-15 in the development of osteoclasts: Inability to replace its activity with IL-2, J. Immunol., 162, 2754, 10.4049/jimmunol.162.5.2754 · DOI
- Djaafar, 2010, Inhibition of T cell-dependent and RANKL-dependent osteoclastogenic processes associated with high levels of bone mass in interleukin-15 receptor-deficient mice, Arthritis Rheum., 62, 3300, 10.1002/art.27645 · DOI
- Henningsson, 2012, Interleukin 15 mediates joint destruction in Staphylococcus aureus arthritis, J. Infect. Dis., 206, 687, 10.1093/infdis/jis295 · DOI
- Verdrengh, 2010, RANKL-targeted therapy inhibits bone resorption in experimental Staphylococcus aureus-induced arthritis, Bone, 46, 752, 10.1016/j.bone.2009.10.028 · DOI
- Deng, 2000, The major role of macrophages and their product tumor necrosis factor alpha in the induction of arthritis triggered by bacterial DNA containing CpG motifs, Arthritis Rheum., 43, 2283, 10.1002/1529-0131(200010)43:10<2283::AID-ANR16>3.0.CO;2-9 · doi:10.1002/1529-0131(200010)43:10<2283::aid-anr16>3.0.co;2-9
- Small, 2008, NK cells play a critical protective role in host defense against acute extracellular Staphylococcus aureus bacterial infection in the lung, J. Immunol., 180, 5558, 10.4049/jimmunol.180.8.5558 · DOI
- Laarman, 2011, Staphylococcus aureus metalloprotease aureolysin cleaves complement C3 to mediate immune evasion, J. Immunol., 186, 6445, 10.4049/jimmunol.1002948 · DOI · Paper page
- Laarman, 2010, Complement inhibition by gram-positive pathogens: Molecular mechanisms and therapeutic implications, J. Mol. Med. (Berl.), 88, 115, 10.1007/s00109-009-0572-y · DOI
- Sakiniene, 1999, Complement depletion aggravates Staphylococcus aureus septicaemia and septic arthritis, Clin. Exp. Immunol., 115, 95, 10.1046/j.1365-2249.1999.00771.x · DOI
- Na, M., Jarneborn, A., Ali, A., Welin, A., Magnusson, M., Stokowska, A., Pekna, M., and Jin, T. (2016). Deficiency of the complement component 3 but not factor B aggravates Staphylococcus aureus septic arthritis in mice. Infect. Immun. · DOI
- Andersen, 2006, Cytotoxic T cells, J. Investig. Dermatol., 126, 32, 10.1038/sj.jid.5700001 · DOI · Paper page
- Sakaguchi, 2008, Regulatory T cells and immune tolerance, Cell, 133, 775, 10.1016/j.cell.2008.05.009 · DOI · Paper page
- Tesmer, 2008, Th17 cells in human disease, Immunol. Rev., 223, 87, 10.1111/j.1600-065X.2008.00628.x · DOI · Paper page
- Kidd, 2003, Th1/Th2 balance: The hypothesis, its limitations, and implications for health and disease, Altern. Med. Rev., 8, 223
- Romagnani, 1999, Th1/Th2 cells, Inflamm. Bowel Dis., 5, 285, 10.1097/00054725-199911000-00009 · DOI · Paper page
- Oosterwegel, 1999, The role of CTLA-4 in regulating Th2 differentiation, J. Immunol., 163, 2634, 10.4049/jimmunol.163.5.2634 · DOI
- Ali, 2015, CTLA4 Immunoglobulin but Not Anti-Tumor Necrosis Factor Therapy Promotes Staphylococcal Septic Arthritis in Mice, J. Infect. Dis., 212, 1308, 10.1093/infdis/jiv212 · DOI
- Parker, 2015, CD4+ T cells promote the pathogenesis of Staphylococcus aureus pneumonia, J. Infect. Dis., 211, 835, 10.1093/infdis/jiu525 · DOI
- Jin, 2019, A novel mouse model for septic arthritis induced by Pseudomonas aeruginosa, Sci. Rep., 9, 16868, 10.1038/s41598-019-53434-5 · DOI
- Henningsson, 2010, Interleukin-17A during local and systemic Staphylococcus aureus-induced arthritis in mice, Infect. Immun., 78, 3783, 10.1128/IAI.00385-10 · DOI
- Kwiecinski, 2013, Sulfatide attenuates experimental Staphylococcus aureus sepsis through a CD1d-dependent pathway, Infect. Immun., 81, 1114, 10.1128/IAI.01334-12 · DOI
- Sonnenberg, 2019, Functional interactions between innate lymphoid cells and adaptive immunity, Nat. Rev. Immunol., 19, 599, 10.1038/s41577-019-0194-8 · DOI · Paper page
- Ali, 2017, Platelets Mediate Host Defense against Staphylococcus aureus through Direct Bactericidal Activity and by Enhancing Macrophage Activities, J. Immunol., 198, 344, 10.4049/jimmunol.1601178 · DOI
- Hultgren, 1998, TNF/lymphotoxin-alpha double-mutant mice resist septic arthritis but display increased mortality in response to Staphylococcus aureus, J. Immunol., 161, 5937, 10.4049/jimmunol.161.11.5937 · DOI
- Hultgren, 2002, Critical role of signaling through IL-1 receptor for development of arthritis and sepsis during Staphylococcus aureus infection, J. Immunol., 168, 5207, 10.4049/jimmunol.168.10.5207 · DOI
- Lenski, 2014, The significance of interleukin-6 and lactate in the synovial fluid for diagnosing native septic arthritis, Acta Orthop. Belg., 80, 18
- Hultgren, 2001, Role of IL-12 in Staphylococcus aureus-triggered arthritis and sepsis, Arthritis Res., 3, 41, 10.1186/ar138 · DOI
- Hultgren, 1998, Staphylococcus aureus-induced septic arthritis and septic death is decreased in IL-4-deficient mice: Role of IL-4 as promoter for bacterial growth, J. Immunol., 160, 5082, 10.4049/jimmunol.160.10.5082 · DOI
- Hultgren, 1999, Outcome of Staphylococcus aureus-triggered sepsis and arthritis in IL-4-deficient mice depends on the genetic background of the host, Eur. J. Immunol., 29, 2400, 10.1002/(SICI)1521-4141(199908)29:08<2400::AID-IMMU2400>3.0.CO;2-E · doi:10.1002/(sici)1521-4141(199908)29:08<2400::aid-immu2400>3.0.co;2-e
- Gjertsson, 2002, Interleukin-10 ameliorates the outcome of Staphylococcus aureus arthritis by promoting bacterial clearance, Clin. Exp. Immunol., 130, 409, 10.1046/j.1365-2249.2002.01999.x · doi:10.1046/j.1365-2249.2002.01999.x
- Zhao, 1998, The dual role of interferon-gamma in experimental Staphylococcus aureus septicaemia versus arthritis, Immunology, 93, 80, 10.1046/j.1365-2567.1998.00407.x · DOI
- Jarneborn, 2020, Tofacitinib treatment aggravates Staphylococcus aureus septic arthritis, but attenuates sepsis and enterotoxin induced shock in mice, Sci. Rep., 10, 10891, 10.1038/s41598-020-67928-0 · DOI
- Davis, 2011, The role of cytokines in the pathogenesis and treatment of systemic lupus erythematosus, J. Interferon Cytokine Res., 31, 781, 10.1089/jir.2011.0047 · DOI
- Osiri, 1998, IL-1beta, IL-6 and TNF-alpha in synovial fluid of patients with non-gonococcal septic arthritis, Asian Pac. J. Allergy Immunol., 16, 155
- Na, M., Wang, W., Fei, Y., Josefsson, E., Ali, A., and Jin, T. (2017). Both anti-TNF and CTLA4 Ig treatments attenuate the disease severity of staphylococcal dermatitis in mice. PLoS ONE, 12. · DOI
- Jacques, 2006, The role of IL-1 and IL-1Ra in joint inflammation and cartilage degradation, Vitam. Horm., 74, 371, 10.1016/S0083-6729(06)74016-X · DOI · Paper page
- Zhao, 1995, Impact of interferon-gamma receptor deficiency on experimental Staphylococcus aureus septicemia and arthritis, J. Immunol., 155, 5736, 10.4049/jimmunol.155.12.5736 · DOI
- 1998, Cytokines induce the development of functionally heterogeneous T helper cell subsets, Immunity, 8, 275, 10.1016/S1074-7613(00)80533-6 · DOI · Paper page
- Ivanov, 2009, Interleukin-17 as a drug target in human disease, Trends Pharmacol. Sci., 30, 95, 10.1016/j.tips.2008.11.004 · DOI
- Sharff, 2013, Clinical management of septic arthritis, Curr. Rheumatol. Rep., 15, 332, 10.1007/s11926-013-0332-4 · DOI
- Tarkowski, 2006, Infection and musculoskeletal conditions: Infectious arthritis, Best Pract. Res. Clin. Rheumatol., 20, 1029, 10.1016/j.berh.2006.08.001 · DOI
- Goldenberg, 1998, Septic arthritis, Lancet, 351, 197, 10.1016/S0140-6736(97)09522-6 · DOI · Paper page
- Balsa, 2011, Septic arthritis, Best Pract. Res. Clin. Rheumatol., 25, 407, 10.1016/j.berh.2011.02.001 · DOI · Paper page
- Mathews, 2010, Bacterial septic arthritis in adults, Lancet, 375, 846, 10.1016/S0140-6736(09)61595-6 · DOI · Paper page
- Morgan, 1996, An 18 year clinical review of septic arthritis from tropical Australia, Epidemiol. Infect., 117, 423, 10.1017/S0950268800059070 · DOI · Paper page
- Fowler, 1998, Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: Experience with 244 patients, Clin. Infect. Dis., 27, 478, 10.1086/514686 · DOI · Paper page
- Marr, 1998, Incidence and outcome of Staphylococcus aureus bacteremia in hemodialysis patients, Kidney Int., 54, 1684, 10.1046/j.1523-1755.1998.00134.x · DOI · Paper page
- Naber, 2009, Staphylococcus aureus bacteremia: Epidemiology, pathophysiology, and management strategies, Clin. Infect. Dis., 48, S231, 10.1086/598189 · DOI · Paper page
- Holland, 2014, Clinical management of Staphylococcus aureus bacteremia: A review, JAMA, 312, 1330, 10.1001/jama.2014.9743 · DOI · Paper page
- Martin, 2012, Sepsis, severe sepsis and septic shock: Changes in incidence, pathogens and outcomes, Expert. Rev. Anti Infect. Ther., 10, 701, 10.1586/eri.12.50 · DOI · Paper page
- Kuiper, 2003, Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock, Clin. Microbiol. Rev., 16, 379, 10.1128/CMR.16.3.379-414.2003 · DOI · Paper page
- Huttunen, 2011, New concepts in the pathogenesis, diagnosis and treatment of bacteremia and sepsis, J. Infect., 63, 407, 10.1016/j.jinf.2011.08.004 · DOI
- Semeraro, 2010, Sepsis-associated disseminated intravascular coagulation and thromboembolic disease, Mediterr. J. Hematol. Infect. Dis., 2, e2010024, 10.4084/mjhid.2010.024 · DOI · Paper page
- Romling, 2012, Biofilm infections, their resilience to therapy and innovative treatment strategies, J. Intern. Med., 272, 541, 10.1111/joim.12004 · DOI · Paper page
- Stoodley, 2008, Direct demonstration of viable Staphylococcus aureus biofilms in an infected total joInt. arthroplasty. A case report, J. Bone Joint Surg. Am., 90, 1751, 10.2106/JBJS.G.00838 · DOI · Paper page
- Dastgheyb, 2015, Effect of biofilms on recalcitrance of staphylococcal joInt. infection to antibiotic treatment, J. Infect. Dis., 211, 641, 10.1093/infdis/jiu514 · DOI · Paper page
- Davies, 2003, Understanding biofilm resistance to antibacterial agents, Nat. Rev. Drug Discov., 2, 114, 10.1038/nrd1008 · DOI · Paper page
- Kwiecinski, 2015, Biofilm formation by Staphylococcus aureus isolates from skin and soft tissue infections, Curr. Microbiol., 70, 698, 10.1007/s00284-014-0770-x · DOI
- Otto, 2013, Staphylococcal infections: Mechanisms of biofilm maturation and detachment as critical determinants of pathogenicity, Annu. Rev. Med., 64, 175, 10.1146/annurev-med-042711-140023 · DOI · Paper page
- Kwiecinski, 2015, Tissue Plasminogen Activator Coating on Implant Surfaces Reduces Staphylococcus aureus Biofilm Formation, Appl. Environ. Microbiol., 82, 394, 10.1128/AEM.02803-15 · DOI
- Libertucci, 2019, The role of the microbiota in infectious diseases, Nat. Microbiol., 4, 35, 10.1038/s41564-018-0278-4 · DOI · Paper page
- Sewankambo, 1997, HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis, Lancet, 350, 546, 10.1016/S0140-6736(97)01063-5 · DOI · Paper page
- Hyoju, S.K., Zaborin, A., Keskey, R., Sharma, A., Arnold, W., van den Berg, F., Kim, S.M., Gottel, N., Bethel, C., and Charnot-Katsikas, A. (2019). Mice Fed an Obesogenic Western Diet, Administered Antibiotics, and Subjected to a Sterile Surgical Procedure Develop Lethal Septicemia with Multidrug-Resistant Pathobionts. mBio, 10. · DOI
- Wu, 2010, Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells, Immunity, 32, 815, 10.1016/j.immuni.2010.06.001 · DOI · Paper page
- Jubair, 2018, Modulation of Inflammatory Arthritis in Mice by Gut Microbiota Through Mucosal Inflammation and Autoantibody Generation, Arthritis Rheumatol., 70, 1220, 10.1002/art.40490 · DOI · Paper page
- Breban, 2017, Faecal microbiota study reveals specific dysbiosis in spondyloarthritis, Ann. Rheum. Dis., 76, 1614, 10.1136/annrheumdis-2016-211064 · DOI · Paper page
- Ulici, 2018, Osteoarthritis induced by destabilization of the medial meniscus is reduced in germ-free mice, Osteoarthr. Cartil., 26, 1098, 10.1016/j.joca.2018.05.016 · DOI
- Henrotin, Y., Patrier, S., Pralus, A., Roche, M., and Nivoliez, A. (2019). Protective Actions of Oral Administration of Bifidobacterium longum CBi0703 in Spontaneous Osteoarthritis in Dunkin Hartley Guinea Pig Model. Cartilage, 1947603519841674. · doi:10.1177/1947603519841674
- Rios, 2019, Protective effect of prebiotic and exercise intervention on knee health in a rat model of diet-induced obesity, Sci. Rep., 9, 3893, 10.1038/s41598-019-40601-x · DOI
- Kaandorp, 1995, Risk factors for septic arthritis in patients with joint disease. A prospective study, Arthritis Rheum., 38, 1819, 10.1002/art.1780381215 · DOI · Paper page
- Walsh, 2010, Bone remodeling in rheumatic disease: A question of balance, Immunol. Rev., 233, 301, 10.1111/j.0105-2896.2009.00857.x · DOI · Paper page
- Udagawa, 1990, Origin of osteoclasts: Mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells, Proc. Natl. Acad. Sci. USA, 87, 7260, 10.1073/pnas.87.18.7260 · DOI · Paper page
- Fei, 2011, The combination of a tumor necrosis factor inhibitor and antibiotic alleviates staphylococcal arthritis and sepsis in mice, J. Infect. Dis., 204, 348, 10.1093/infdis/jir266 · DOI
- Ali, A., Na, M., Svensson, M.N., Magnusson, M., Welin, A., Schwarze, J.C., Mohammad, M., Josefsson, E., Pullerits, R., and Jin, T. (2015). IL-1 Receptor Antagonist Treatment Aggravates Staphylococcal Septic Arthritis and Sepsis in Mice. PLoS ONE, 10. · DOI
- Okusawa, 1988, Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition, J. Clin. Investig., 81, 1162, 10.1172/JCI113431 · DOI · Paper page
- Wang, 1999, HMG-1 as a late mediator of endotoxin lethality in mice, Science, 285, 248, 10.1126/science.285.5425.248 · DOI · Paper page
- Fisher, 1996, Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group, N. Engl. J. Med., 334, 1697, 10.1056/NEJM199606273342603 · DOI · Paper page
- Richter, 2016, Impact of treatment with biologic DMARDs on the risk of sepsis or mortality after serious infection in patients with rheumatoid arthritis, Ann. Rheum. Dis., 75, 1667, 10.1136/annrheumdis-2015-207838 · DOI
- Fattahi, 2017, Understanding Immunosuppression after Sepsis, Immunity, 47, 3, 10.1016/j.immuni.2017.07.007 · DOI
- Lowy, 1998, Staphylococcus aureus infections, N. Engl. J. Med., 339, 520, 10.1056/NEJM199808203390806 · DOI · Paper page
- Miller, 2020, Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms, FEMS Microbiol. Rev., 44, 123, 10.1093/femsre/fuz030 · DOI · Paper page
- Smith, 1997, Staphylococcal septic arthritis: Antibiotic and nonsteroidal anti-inflammatory drug treatment in a rabbit model, J. Orthop. Res., 15, 919, 10.1002/jor.1100150619 · doi:10.1002/jor.1100150619
- Ferreira, 2018, A Recurrent De Novo Heterozygous COG4 Substitution Leads to Saul-Wilson Syndrome, Disrupted Vesicular Trafficking, and Altered Proteoglycan Glycosylation, Am. J. Hum. Genet., 103, 553, 10.1016/j.ajhg.2018.09.003 · DOI
- Sakiniene, 1996, Addition of corticosteroids to antibiotic treatment ameliorates the course of experimental Staphylococcus aureus arthritis, Arthritis Rheum., 39, 1596, 10.1002/art.1780390921 · DOI
- Odio, 2003, Double blind, randomized, placebo-controlled study of dexamethasone therapy for hematogenous septic arthritis in children, Pediatr. Infect. Dis. J., 22, 883, 10.1097/01.inf.0000091293.32187.7b · DOI
Cited by
Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms
Touaitia, R., Mairi, A., Ibrahim, N. A., Basher, N. S., Idres, T., & Touati, A. (2025) · Antibiotics · doi:10.3390/antibiotics14050470 · Cited by 273
Metadata
- Authors
- Jin, T., Mohammad, M., Pullerits, R., & Ali, A.
- Venue
- Pathogens
- Publisher
- MDPI AG
- Published
- 2021-02-03
- Volume
- 10
- Issue
- 2
- Pages
- 158
- ISSN
- 2076-0817
- Cited by
- 76
- References
- 18
- Language
- en
- Funders
- Vetenskapsrådet (2019-01135)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bacteria and Host Interplay in Staphylococcus aureus Septic Arthritis and Sepsis. https://app.cochat.ai/papers/10.3390/pathogens10020158
- The paper
- Jin, T., Mohammad, M., Pullerits, R., & Ali, A. (2021). Bacteria and Host Interplay in Staphylococcus aureus Septic Arthritis and Sepsis. Pathogens. https://doi.org/10.3390/pathogens10020158
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.